Search clinical trials for: Irbesartan (Aprovel)

Total 489 results

Hanmi Pharmaceutical Company Limited

Completed

A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin

Healthy

Korea, Republic of
Omega Ophthalmics

Completed

Clinical Investigation of Omega Refractive Capsule Model V With Use of an FDA Approved IOL (ORCV)

Cataract

Costa Rica
ProVerum Medical

Active, not recruiting

ProVee Urethral Expander System IDE Study (ProVIDE) (ProVIDE)

Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms

Ireland, United States, Canada
Sun Yat-sen University

Completed

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)

IgA Nephropathy

China
Sanofi

Completed

Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension (COSIMA2)

Hypertension

India, Malaysia, Philippines, Singapore, Taiwan, Tunisia, Egypt, Korea, Republic of, Hong Kong, Indonesia, Morocco, Pakistan, Thailand, Vietnam
Mario Negri Institute for Pharmacological Research

Completed

Sevelamer in Proteinuric CKD (ANSWER)

Chronic Kidney Disease

Italy
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions

Hypertension

United States
Sanofi

Completed

ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination (ACTUAL)

Hypertension

Brazil, Tunisia, Argentina, Egypt, Mexico, Peru, Morocco, Colombia, Guatemala, Venezuela, Lebanon, Algeria, Ecuador, Panama, Saudi Arabia, United Arab Emirates
Handok Inc.

Completed

Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients

Essential Hypertension

Korea, Republic of
ProVerum Medical

Completed

The ProVerum First in Man PROVE Study

Benign Prostatic Hyperplasia

Australia
Huntridge Family Clinic

Unknown

What Happens in Vegas: PEP to PrEP Opportunities

Exposure to Human Immunodeficiency Virus (Event)

United States
Omega Ophthalmics

Active, not recruiting

Clinical Investigation of Omega Refractive Capsule, Model VI (ORCVI)

Cataract

Costa Rica
Handok Inc.

Completed

Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy Volunteers

Healthy Volunteers

Korea, Republic of
Handok Inc.

Completed

Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension

Essential Hypertension

Korea, Republic of
University of Wisconsin, Madison

Completed

Asthma and Obstructive Sleep Apnea (OSA)

Asthma | Obstructive Sleep Apnea

United States
Fresenius Kabi SwissBioSim GmbH

Completed

MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis

Rheumatoid Arthritis

Hungary, Serbia, Georgia, Russian Federation, Slovakia, Czechia, Bulgaria, Moldova, Republic of, Poland
Innovent Biologics (Suzhou) Co. Ltd.

Completed

A PK Similarity Study of Two Sintilimab Products Produced by Different Processes in Advanced or Metastatic NSCLC Patients

Advanced or Metastatic NSCLC

China
University of Erlangen-Nürnberg Medical School
Bristol-Myers Squibb

Completed

Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia

Hypercholesterolemia

Germany
Sanofi
Bristol-Myers Squibb

Completed

Irbesartan in Hypertension

Hypertension

Turkey
Sanofi
Bristol-Myers Squibb

Completed

APROVE : Irbesartan in Hypertension

Hypertension

Algeria
Sanofi
Bristol-Myers Squibb

Completed

Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice

Hypertension

Tunisia
Sanofi
Bristol-Myers Squibb

Completed

Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria

Hypertension

China
Sanofi

Completed

Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy (I-COMBINE)

Hypertension

Brazil, Chile, Colombia, Egypt, Lebanon, Mexico, Morocco, Tunisia, Venezuela
Sanofi

Completed

Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension

Hypertension
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants

Neutropenia

Australia
LG Life Sciences

Completed

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects

Healthy

Korea, Republic of
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions

Hypertension

United States
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)

Congestive Heart Failure

Netherlands, Portugal, Spain, United States, Belgium, Italy, Argentina, Brazil, Canada, France, Germany, Mexico, South Africa, Sweden, Australia, Russian Federation, Poland, Czech Republic, Denmark, Ireland, Hungary, Switzerland, Gr... and more
Pfizer

Completed

A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers

Healthy Volunteers

United States
Handok Inc.

Completed

Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy Volunteers

Healthy Volunteers

Korea, Republic of
University of Edinburgh
Maastricht University Medical Center; Erasmus Medical Center; INIS Collaborative...

Completed

Neurodevelopmental Outcomes After Suspected or Proven Sepsis: Secondary Analysis of INIS Trial Database

Neonatal Sepsis
Brigham and Women's Hospital

Suspended

Preeclampsia: A Marker for Future Cardiovascular Risk in Women

Preeclampsia | Pregnancy Induced Hypertension

United States
Sanofi
Bristol-Myers Squibb

Completed

ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation

Myocardial Ischemia | Hypertension

France, Spain, Italy, Belgium, Canada, Germany, Hungary, United States, Netherlands, United Kingdom, Switzerland
Connolly, Stuart, M.D.
Bristol-Myers Squibb; Sanofi

Unknown

Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers

Hypertension | Atrial Fibrillation

Canada
National Cancer Institute, Naples
Federico II University; University of Campania "Luigi Vanvitelli"

Terminated

Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors (LOTUS)

Neuroendocrine Tumors

Italy
Augusta University

Unknown

Effectiveness of Avapro in Obese Normotensive/Hypertensive African Americans (Avapro3)

Hypertension | Obesity | Stress, Psychological | Blood Pressure

United States
Charite University, Berlin, Germany
Bristol-Myers Squibb

Completed

Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure

Chronic Heart Failure

Germany
Sanofi
Bristol-Myers Squibb

Completed

Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria (PRIME)

Hypertension
Hippocration General Hospital
National and Kapodistrian University of Athens

Recruiting

The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.

Obesity | Primary Hypertension

Greece
Assistance Publique - Hôpitaux de Paris

Completed

PHARES Study: Management of Resistant Hypertension

Hypertension

France
Fudan University
Huazhong University of Science and Technology; LinkDoc Technology (Beijing)...

Recruiting

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

Triple-negative Breast Cancer | Carcinoma Breast | Invasive Ductal Carcinoma, Breast

China
Baltimore VA Medical Center

Completed

Intermittent Pneumatic Compression of the Upper Extremity for Post-Operative VTE Prophylaxis

Venous Thromboses
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Completed

Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE) (ARCADE)

Ehlers-Danlos Syndrome, Vascular Type

France
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted Conditions

Hypertension

United States
Celltrion

Recruiting

A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects

Healthy Subjects

Korea, Republic of
Fudan University
Huazhong University of Science and Technology; LinkDoc Technology (Beijing)...

Recruiting

Huaier Granule on Reducing the Level of Tumor Markers in Patients With Early-stage Breast Cancer

Early-stage Breast Cancer

China
ANRS, Emerging Infectious Diseases
Sanofi

Completed

Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C (Fibrosar)

Hepatitis C, Chronic

France
Coopervision, Inc.

Completed

Comparing the Performance of 1 Day Multifocal Contact Lenses

Presbyopia

United States
Philips Clinical & Medical Affairs Global

Completed

At-Home Care for Subjects With Periodontitis

Periodontitis | Dental Plaque

United States
Fresenius Kabi SwissBioSim GmbH

Completed

Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456

Healthy

New Zealand

Search clinical trials for: Irbesartan (Aprovel)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations